AOD 9604 10mg*10vials*1kits – Best Eeffect Hiqh Purity Peptides Product

Description

AOD 9604 10mg HGH Frag 176-191 Analog Weight Loss Research

About This Compound

AOD 9604 (Advanced Obesity Drug) is a structurally modified, synthetic C-terminal fragment of human growth hormone, specifically encompassing the 177-191 sequence. By strategically integrating an N-terminal tyrosine residue, researchers have effectively created a highly stabilized peptide chain that isolates the lipolytic and anti-lipogenic properties of natural somatotropin.

Chemical Properties

• CAS Number: 221231-10-3
• Molecular Formula: C78H123N23O23S2
• Molecular Weight: 1815.1 g/mol
• Purity: >99% (HPLC validated)
• Appearance: Sterile filtered white lyophilized powder

How It Works

AOD 9604 specifically targets adipose tissue architecture to aggressively modulate lipid metabolism. The modified peptide binds directly to the beta-3 adrenergic receptors situated on the adipocyte membrane. This highly specific interaction triggers an intracellular cyclic AMP (cAMP) signaling cascade. The resulting cascade directly upregulates the expression and activity of hormone-sensitive lipase. Compared to the standard, unmodified HGH Fragment 176-191, the addition of the tyrosine residue provides superior resistance against rapid proteolytic cleavage, extending the biological half-life to approximately 40 to 50 minutes in vivo. Crucially, the compound exhibits an undetectable binding affinity for the systemic IGF-1 receptor, fundamentally ensuring strictly lipolytic outcomes devoid of unwanted structural tissue hypertrophy or altered glucose homeostasis.

Known Effects

• Study findings show an accelerated rate of localized fat oxidation, particularly surrounding stubborn visceral adipose deposits.
• Anecdotal evidence strongly suggests a sustained suppression of lipogenesis, effectively mitigating new lipid accumulation during caloric surpluses.
• Aggregated data shows the complete absence of insulin resistance, a common adverse effect associated with full-sequence growth hormone.
• Researchers note a mild, consistent elevation in baseline energy expenditure secondary to continuous free fatty acid mobilization.

Key Points:
AOD 9604 provides researchers with an optimized, highly stable lipolytic peptide specifically engineered to evaluate beta-3 mediated fat oxidation without systemic endocrine disruption.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.